Across TCGA pan-cancer cohorts, LINC00970 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00970 data layer.
The strongest signal is observed in sarcoma (SARC), where higher LINC00970 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00970 expression acts as an unfavorable survival marker, although some lineages such as ACC and HNSC show a favorable association.
SARC, ACC, and HNSC are the cancer types where LINC00970 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.